Rockwell Medical, Inc. (RMTI) Financial Statements (2023 and Earlier)

Company Profile

Business Address 30142 WIXOM ROAD
WIXOM, MI 48393
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including: 58,70026,04533,53233,05557,94070,681
Cash and cash equivalents 48,68211,79522,7148,40717,18131,198
Short-term investments 9,99714,25010,81824,64840,76039,483
Other undisclosed cash, cash equivalents, and short-term investments 21     
Receivables 4,1714,2037,3516,3566,3935,047
Inventory, net of allowances, customer advances and progress billings 3,9133,6474,0397,63712,1417,872
Inventory 3,9133,6474,0397,63712,1417,872
Other current assets    1,7802,0351,027
Other undisclosed current assets 2,6852,9801,904   
Total current assets: 69,46936,87446,82548,82878,50984,626
Noncurrent Assets
Inventory, Noncurrent 1,1764411,6375,9871,827 
Operating lease, right-of-use asset 2,9113,213
Property, plant and equipment 2,6422,4332,6382,5491,3921,647
Intangible assets, net (including goodwill) 9219219219259251,086
Goodwill 921921921921921921
Intangible assets, net (excluding goodwill)    44166
Other noncurrent assets 629435537491501463
Total noncurrent assets: 8,2797,4435,7339,9514,6443,196
TOTAL ASSETS: 77,74844,31652,55858,78083,15487,822
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 9,1687,5369,6228,93810,0687,827
Accounts payable 4,1553,0184,4924,2225,8583,995
Accrued liabilities 5,0134,5185,1304,7164,2103,831
Deferred revenue 2,1752,234
Debt  1,493    
Estimated litigation liability  104417   
Due to related parties 131188850   
Customer advances and deposits20577265
Other undisclosed current liabilities 1,3198192,316   
Total current liabilities: 12,79312,37413,2059,14310,1468,091
Noncurrent Liabilities
Long-term debt and lease obligation 22,7701,781    
Long-term debt, excluding current maturities 20,949     
Operating lease, liability 1,8211,781
Liabilities, other than long-term debt 8,0159,843 16,723  
Deferred revenue and credits16,723  
Deferred revenue 8,0159,843
Other undisclosed noncurrent liabilities   12,076   
Total noncurrent liabilities: 30,78511,62312,07616,723  
Total liabilities: 43,57823,99725,28125,86610,1468,091
Stockholders' equity
Stockholders' equity attributable to parent, including: 34,17020,32027,27732,91352,95662,320
Common stock     268,200257,773
Additional paid in capital 371,510326,777    
Accumulated other comprehensive income (loss) 575263(35)(903)(915)
Accumulated deficit (337,406)(306,516)(272,388)(240,262)(214,341)(194,538)
Other undisclosed stockholders' equity attributable to parent 97299,602273,211  
Total stockholders' equity: 34,17020,32027,27732,91352,95662,320
Other undisclosed liabilities and equity     20,05217,411
TOTAL LIABILITIES AND EQUITY: 77,74844,31652,55858,78083,15487,822

Income Statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 62,19761,30363,38957,30053,28455,351
Revenue, net57,30053,28455,351
Cost of revenue
(Cost of Goods and Services Sold)
 (59,472)(58,464)(64,973)(53,598)(46,532)(46,413)
Gross profit: 2,7252,839(1,585)3,7026,7538,938
Operating expenses (31,145)(37,364)(29,755)(29,625)(26,961)(24,040)
Other undisclosed operating loss   (1,100)   
Operating loss: (28,420)(34,525)(32,439)(25,923)(20,209)(15,102)
Nonoperating income (expense) (2,470)3973132810682
Investment income, nonoperating    1810682
Foreign currency transaction gain, before tax    1  
Other nonoperating income (expense) (2,470)397313   
Interest and debt expense (1,879)     
Loss from continuing operations before income taxes: (32,769)(34,128)(32,126)(25,921)(19,398)(14,420)
Income tax expense     (405) 
Net loss: (32,769)(34,128)(32,126)(25,921)(19,803)(14,420)
Other undisclosed net income attributable to parent 1,879     
Net loss available to common stockholders, diluted: (30,890)(34,128)(32,126)(25,921)(19,803)(14,420)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss: (32,769)(34,128)(32,126)(25,921)(19,803)(14,420)
Comprehensive loss: (32,769)(34,128)(32,126)(25,921)(19,803)(14,420)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 1,884(11)9986713(718)
Comprehensive loss, net of tax, attributable to parent: (30,885)(34,139)(32,027)(25,054)(19,790)(15,138)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: